Gilead's remdesivir to be tested with Merck KGaA's interferon vs. COVID by NIH
The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.'s GILD, +0.07% remdesivir with Merck KGaA's MRK, -0.35% interferon beta-1a as a treatment for COVID-19 patients. The study plans to enroll 1,000 people who have been hospitalized because of a COVID-19 infection. The federal agency said it expects to have preliminary results in the fall.
's Olumiant. Roche Holding AG ROG, +0.38% has also said it will test its rheumatoid arthritis drug in combination with remdesivir.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Alyssa Milano Reveals She Had COVID-19 and Felt Like She 'Was Dying'The actress tested positive for COVID-19 antibodies after getting three negative test results.
Weiterlesen »
In communities of color, one organization is helping to fill the COVID-19 testing gapIn communities of color, one organization is helping to fill the COVID-19 testing gap.
Weiterlesen »
Students at school touted by Pence for reopening must quarantine due to COVID-19Students at school touted by Mike Pence for reopening must quarantine after positive COVID-19 test
Weiterlesen »
Think you need a COVID-19 test? The nation's testing czar says you might not.Easing demands on COVID-19 testing could shorten wait times for people to get their results.
Weiterlesen »
Alaska cruise cut short after passenger tests positive for COVID-19One of the first U.S. cruises to resume sailing amid the novel coronavirus pandemic was cut short after a passenger tested positive for COVID-19.
Weiterlesen »
Ohio Gov. Mike DeWine tests negative on second COVID-19 testOhio Gov. Mike DeWine has tested positive for COVID-19. DeWine was tested before he was supposed to meet President Donald Trump on Thursday.
Weiterlesen »